An Open-Label, Two-Group Study to Investigate the Effect of Food (Group 1) and Esomeprazole (Group 2) on the Single Oral Dose Pharmacokinetics of RO5424802 in Healthy Subjects
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Alectinib (Primary) ; Esomeprazole
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Roche
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 19 Aug 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2014 New trial record